This is a good informative read-------------------
https://www.news-medical.net/health/What-are-Smart-Inhalers.aspx
COPD affects over 200 million people the world over, and asthma another 300 million. Chronic respiratory disease makes up a little over 8% of the world’s chronic disease burden.
In order to mitigate the clinical severity of these conditions, patients need to adhere to a strict medication schedule, with the dosage and timing being adjusted to achieve control of their symptoms.
Inhalers are essential for observing the strict regimen required for these conditions, as they avoid the need for and the adverse effects associated with the use of injectables and oral drugs.
Nonetheless, many patients tend to misuse the freedom that comes with the use of inhalers by ignoring the recommended treatment schedule, failing to stock refills before the last one is empty,
However, the way medicine is being practiced has undergone dramatic changes with the development of novel technologies that help examine the health of the patient as a whole. This is particularly so with the Internet of Things (IoT).Now that the internet has become a standard component of daily life, whether at home, the workplace or school, connectivity is the watchword for all kinds of technological processes. Such connectivity was earlier achieved by wireless (wi-fi) or Bluetooth networks, but now artificial intelligence (AI) is giving rise to new-generation medical devices that deliver smart care.
The inhaler is part of this transformation, with smart inhalers having emerged on the scene.
A smart inhaler is an inhaler that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use.
The world’s first smart inhaler to receive approval from the Food and Drug Administration (FDA) was Teva's ProAir Digihaler (albuterol sulfate), which has a use-tracking real-time sensor that syncs it to a mobile app.
The sensors may be either an integral part of the inhaler itself or be external devices that are attached to the primary inhaler. Several devices now being developed belong to the latter clip-on category, such as that from the United States-based company Propeller Health and New Zealand-based Adherium.
- Forums
- ASX - By Stock
- What are Smart Inhalers
ADR
adherium limited
Add to My Watchlist
0.00%
!
0.5¢

This is a good informative...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.384M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 5091095 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 5585535 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 5091095 | 0.004 |
19 | 6296591 | 0.003 |
8 | 14000000 | 0.002 |
4 | 27000000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 5585535 | 5 |
0.006 | 1136831 | 2 |
0.007 | 1606269 | 8 |
0.008 | 1450124 | 4 |
0.009 | 1007118 | 3 |
Last trade - 16.21pm 19/09/2025 (20 minute delay) ? |
Featured News
ADR (ASX) Chart |